Revelation Biosciences

REVBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.904 M

$0.98 +0.38%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$8.91M

Loss-making

Shares outstanding

3,983,416

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Revelation Biosciences lists more than one class of stock. Company figures above cover all classes combined.

REVBW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#471Jupiter NeurosciencesJUNS$3.93M
#472Sunshine BiopharmaSBFM$3.91M
#473Revelation BiosciencesREVB$3.90M
#474Shuttle PharmaceuticalsSHPH$3.86M
#475Galmed PharmaceuticalsEOCN$3.78M

What if Revelation Biosciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$7,589,960

Per share 7,744,857× higher

Bitcoin $1.74T

$437,226.47

Per share 446,149× higher

Nvidia $5.52T

$1,384,683

Per share 1,412,941× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Revelation Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.